Literature DB >> 16357453

Risk factors for hospital-acquired bacteremia.

Takuhiro Yoshida1, Kenji Tsushima, Ayako Tsuchiya, Noriko Nishikawa, Kumiko Shirahata, Kazuma Kaneko, Ken-Ichi Ito, Hirotaka Kawakami, Shin-Ichi Nakagawa, Toshiro Suzuki, Keishi Kubo, Shu-Ichi Ikeda.   

Abstract

OBJECTIVE: Bacteremia is one of the most serious health problems associated with high morbidity and mortality. The aim of this study was to identify risk factors for bacteremia in daily medical care to facilitate rapid and accurate clinical decisions about treatment. PATIENTS AND METHODS: We studied 306 inpatients retrospectively. Age, peripheral neutrophil count, C-reactive protein (CRP), platelets, serum total cholesterol, total protein, albumin and cholinesterase were compared in patients with positive- and negative-blood cultures. The associations between blood culture positivity and glucose tolerance, bedridden state, presence of a central venous catheter (CVC) or urinary catheter were examined. On October 14, 2002, strategies for prevention of catheter-related infection were altered in our hospital. We studied the impact of these changes on the risk of bacteremia.
RESULTS: Sixty-seven patients had positive and 239 had negative blood cultures. Age, neutrophil, platelets, total protein, albumin, and cholinesterase were significantly different between the culture-positive patients and the culture-negative patients. Multivariate analysis showed albumin and platelets as independent predictors. The bedridden state and catheter-inserted states (central venous or urinary) conferred significantly higher positive blood culture rates. Multivariate analysis showed using urinary catheters and indwelling femoral CVCs as independent risk factors. There was no significant difference in the blood culture-positive rate before and after the change in prevention strategies; before the change, 6 of 9 catheter-inserted blood culture-positive cases yielded MRSA, while 4 of 12 cultures yielded Staphylococcus epidermidis after the change.
CONCLUSION: Our study highlights the risk factors of bacteremia in vulnerable patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16357453     DOI: 10.2169/internalmedicine.44.1157

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  8 in total

1.  Sepsis in standard care: patients' characteristics, effectiveness of antimicrobial therapy and patient outcome--a cohort study.

Authors:  Franz Ratzinger; Katharina Eichbichler; Michael Schuardt; Irene Tsirkinidou; Dieter Mitteregger; Helmuth Haslacher; Thomas Perkmann; Klaus G Schmetterer; Georg Doffner; Heinz Burgmann
Journal:  Infection       Date:  2015-04-04       Impact factor: 3.553

2.  Prognostic indicators related to death in patients with Pneumocystis pneumonia associated with collagen vascular diseases.

Authors:  Yoko Aoki; Masahiro Iwamoto; Yasuyuki Kamata; Takao Nagashima; Taku Yoshio; Hitoaki Okazaki; Seiji Minota
Journal:  Rheumatol Int       Date:  2009-01-14       Impact factor: 2.631

3.  Risk factors for incidence and case-fatality rates of healthcare-associated infections: a 20-year follow-up of a hospital-based cohort.

Authors:  R-F Wang; S-H Shen; A M-F Yen; T-L Wang; T-N Jang; S-H Lee; J-T Wang; H-H Chen
Journal:  Epidemiol Infect       Date:  2015-05-20       Impact factor: 4.434

4.  Incidence and clinical implication of nosocomial infections associated with implantable biomaterials - catheters, ventilator-associated pneumonia, urinary tract infections.

Authors:  Josef Peter Guggenbichler; Ojan Assadian; Michael Boeswald; Axel Kramer
Journal:  GMS Krankenhhyg Interdiszip       Date:  2011-12-15

5.  A risk prediction model for screening bacteremic patients: a cross sectional study.

Authors:  Franz Ratzinger; Michel Dedeyan; Matthias Rammerstorfer; Thomas Perkmann; Heinz Burgmann; Athanasios Makristathis; Georg Dorffner; Felix Lötsch; Alexander Blacky; Michael Ramharter
Journal:  PLoS One       Date:  2014-09-03       Impact factor: 3.240

6.  Risk factors for nosocomial bloodstream infections in COVID-19 affected patients: protocol for a case-control study.

Authors:  Carla Codina-Jiménez; Sergio Marin; Marlene Álvarez; Maria Dolores Quesada; Beatriz Rodríguez-Ponga; Ester Valls; Carles Quiñones
Journal:  Eur J Hosp Pharm       Date:  2021-08-16

Review 7.  Platelets in defense against bacterial pathogens.

Authors:  Michael R Yeaman
Journal:  Cell Mol Life Sci       Date:  2009-12-15       Impact factor: 9.261

8.  Risk of infection due to medical interventions via central venous catheters or implantable venous access port systems at the middle port of a three-way cock: luer lock cap vs. luer access split septum system (Q-Syte).

Authors:  Fabian Pohl; Werner Hartmann; Thomas Holzmann; Sandra Gensicke; Oliver Kölbl; Matthias G Hautmann
Journal:  BMC Infect Dis       Date:  2014-01-25       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.